California State Teachers Retirement System trimmed its holdings in Zimmer Biomet Holdings Inc (NYSE:ZBH) by 8.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 354,752 shares of the medical equipment provider’s stock after selling 30,679 shares during the quarter. California State Teachers Retirement System owned approximately 0.18% of Zimmer Biomet worth $41,538,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of ZBH. Bessemer Group Inc. boosted its stake in Zimmer Biomet by 21.1% in the 2nd quarter. Bessemer Group Inc. now owns 4,297 shares of the medical equipment provider’s stock worth $552,000 after purchasing an additional 750 shares during the period. IFP Advisors Inc boosted its stake in Zimmer Biomet by 22.4% in the 2nd quarter. IFP Advisors Inc now owns 2,077 shares of the medical equipment provider’s stock worth $267,000 after purchasing an additional 380 shares during the period. Trexquant Investment LP bought a new position in Zimmer Biomet in the 2nd quarter worth approximately $231,000. Canada Pension Plan Investment Board boosted its stake in Zimmer Biomet by 7.7% in the 2nd quarter. Canada Pension Plan Investment Board now owns 51,861 shares of the medical equipment provider’s stock worth $6,659,000 after purchasing an additional 3,700 shares during the period. Finally, Schwab Charles Investment Management Inc. boosted its stake in Zimmer Biomet by 1.1% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 669,622 shares of the medical equipment provider’s stock worth $85,980,000 after purchasing an additional 7,273 shares during the period. Institutional investors and hedge funds own 86.24% of the company’s stock.

Several research firms have weighed in on ZBH. BMO Capital Markets restated a “buy” rating and issued a $142.00 price target on shares of Zimmer Biomet in a research note on Tuesday. TheStreet downgraded Zimmer Biomet from a “b-” rating to a “c+” rating in a research note on Friday, November 24th. Zacks Investment Research downgraded Zimmer Biomet from a “hold” rating to a “strong sell” rating in a research note on Monday, November 20th. Deutsche Bank upgraded Zimmer Biomet from a “hold” rating to a “buy” rating and set a $128.00 price target for the company in a research note on Tuesday, November 14th. Finally, Edward Jones upgraded Zimmer Biomet from a “hold” rating to a “buy” rating in a research note on Thursday, November 9th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $134.05.

Shares of Zimmer Biomet Holdings Inc (ZBH) traded up $2.42 on Friday, hitting $115.24. The stock had a trading volume of 2,158,057 shares, compared to its average volume of 1,250,446. The stock has a market cap of $22,839.17, a PE ratio of 13.98, a price-to-earnings-growth ratio of 1.75 and a beta of 1.15. Zimmer Biomet Holdings Inc has a twelve month low of $100.87 and a twelve month high of $133.49. The company has a quick ratio of 0.78, a current ratio of 1.47 and a debt-to-equity ratio of 0.88.

Zimmer Biomet (NYSE:ZBH) last released its quarterly earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.74 by ($0.02). Zimmer Biomet had a net margin of 8.36% and a return on equity of 16.29%. The company had revenue of $1.82 billion for the quarter, compared to analysts’ expectations of $1.83 billion. During the same quarter in the previous year, the company posted $1.79 EPS. The business’s quarterly revenue was down .8% on a year-over-year basis. analysts expect that Zimmer Biomet Holdings Inc will post 8.03 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This story was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.watchlistnews.com/zimmer-biomet-holdings-inc-zbh-holdings-trimmed-by-california-state-teachers-retirement-system/1768091.html.

Zimmer Biomet Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings Inc (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with MarketBeat.com's FREE daily email newsletter.